DelAQUA is a specialty pharmaceutical company that has developed a breakthrough drug formulation platform that (a) reformulates poorly soluble marketed drugs to make them safer and more active and (b) formulates insoluble and unstable new chemical entities to make them more bioavailable. Based on leading-edge polymeric science, DelAQUA’s proprietary platform uniquely improves the solubility of active pharmaceutical ingredients (APIs) by using novel polymers at low concentrations that effectively widen the therapeutic index of many APIs. Our mission is to hasten the successful formulation and development of therapies that address the unmet medical needs of patients in a broad spectrum of diseases. DelAQUA is presently collaborating with several multinational Pharmaceutical companies, two smaller pharmaceutical companies and a number of major research universities on soluble drug formulations with the goal of improving the therapeutic window of the drugs and provide additional patent protection to their products.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Chapel Hill, Nc 27514, Us
- Industry
- Biotechnology
- HQ
- Chapel Hill, NC
Delaqua Pharmaceuticals Questions
Delaqua Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/delaqua-pharmaceuticals
Delaqua Pharmaceuticals has
6 employees.
View email and phone details for 6
employees at Delaqua Pharmaceuticals.
Delaqua Pharmaceuticals's industry is
Biotechnology
Delaqua Pharmaceuticals's top competitors are
Innovation Management,
Cempra Pharmaceuticals,
Viamet Pharmaceuticals,
Med Aditus Pharmaceuticals,
Heads Together Health,
Vesselon,
Mizar Therapeutics,
Primeneuro,
Bluesky Polymers,
Southern California Permanente Medical Group.
Delaqua Pharmaceuticals's categories are Biotechnology
Delaqua Pharmaceuticals's founding year is 2018
